Epidiolex | CashCropToday
GW Pharmaceuticals Receives Approval for 5 New Patents for Epidiolex
Market Watch
317 views
Market Watch
317 views

GW Pharmaceuticals Receives Approval for 5 New Patents for Epidiolex

Editor - March 15, 2018

GW Pharmaceuticals (Nasdaq:GWPH) recently announced that their company has received “Notices of Allowance” from the United States Patent and Trademark office for five new Epidiolex® patent applications…

GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing
Health
287 views
Health
287 views

GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing

Editor - February 22, 2018

On February 21, 2018 GW Pharmaceuticals PLC (Nasdaq:GWPH) (“GW,”) announced that a Phase 2a proof of concept study of a pipeline compound GWP42006 in adult patients with…